S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
NASDAQ:TIL

Instil Bio (TIL) Stock Price, News & Analysis

$11.98
+0.06 (+0.50%)
(As of 03/1/2024 ET)
Today's Range
$11.82
$12.09
50-Day Range
$7.10
$11.98
52-Week Range
$6.07
$15.80
Volume
11,026 shs
Average Volume
18,111 shs
Market Capitalization
$77.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$64.00

Instil Bio MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
434.2% Upside
$64.00 Price Target
Short Interest
Healthy
0.30% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of Instil Bio in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($25.40) to ($15.23) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.81 out of 5 stars

Medical Sector

282nd out of 950 stocks

Biological Products, Except Diagnostic Industry

44th out of 159 stocks


TIL stock logo

About Instil Bio Stock (NASDAQ:TIL)

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecule to recognize folate receptor alpha, a tumor-associated antigen that is expressed on various solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

TIL Stock Price History

TIL Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Instil Bio Inc.
Instil Bio Announces Strategic Update
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
TIL Stock Earnings: Instil Bio Misses EPS for Q3 2023
TIL Stock Earnings: Instil Bio Misses EPS for Q1 2023
Instil Bio Shares Fall 7% After Reverse Split News
Instil Bio Inc TIL
Instil Bio Inc
Truist Financial Remains a Hold on Instil Bio (TIL)
See More Headlines
Receive TIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Instil Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/31/2023
Today
3/03/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:TIL
Fax
N/A
Employees
192
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$64.00
High Stock Price Target
$120.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+434.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-223,180,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$56.07 per share

Miscellaneous

Free Float
2,946,000
Market Cap
$77.87 million
Optionable
Optionable
Beta
1.25
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report














TIL Stock Analysis - Frequently Asked Questions

Should I buy or sell Instil Bio stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Instil Bio in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TIL shares.
View TIL analyst ratings
or view top-rated stocks.

What is Instil Bio's stock price target for 2024?

3 equities research analysts have issued 1 year price objectives for Instil Bio's stock. Their TIL share price targets range from $18.00 to $120.00. On average, they anticipate the company's stock price to reach $64.00 in the next twelve months. This suggests a possible upside of 434.2% from the stock's current price.
View analysts price targets for TIL
or view top-rated stocks among Wall Street analysts.

How have TIL shares performed in 2024?

Instil Bio's stock was trading at $7.62 at the beginning of 2024. Since then, TIL stock has increased by 57.2% and is now trading at $11.98.
View the best growth stocks for 2024 here
.

Are investors shorting Instil Bio?

Instil Bio saw a decline in short interest in the month of February. As of February 15th, there was short interest totaling 12,000 shares, a decline of 39.1% from the January 31st total of 19,700 shares. Based on an average daily trading volume, of 45,200 shares, the short-interest ratio is presently 0.3 days. Approximately 0.3% of the shares of the stock are sold short.
View Instil Bio's Short Interest
.

When is Instil Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our TIL earnings forecast
.

How were Instil Bio's earnings last quarter?

Instil Bio, Inc. (NASDAQ:TIL) issued its quarterly earnings data on Friday, March, 31st. The company reported ($8.20) earnings per share for the quarter, topping analysts' consensus estimates of ($9.00) by $0.80.

When did Instil Bio's stock split?

Instil Bio's stock reverse split on the morning of Friday, December 8th 2023. The 1-20 reverse split was announced on Friday, December 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Instil Bio own?
When did Instil Bio IPO?

(TIL) raised $250 million in an IPO on Friday, March 19th 2021. The company issued 13,900,000 shares at $17.00-$19.00 per share. Morgan Stanley, Jefferies, Cowen and Truist Securities served as the underwriters for the IPO.

Who are Instil Bio's major shareholders?

Instil Bio's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Curative Ventures V LLC (29.22%), Vivo Capital LLC (9.61%), Cable Car Capital LLC (3.97%), Vanguard Group Inc. (2.00%), Nantahala Capital Management LLC (1.96%) and Citadel Advisors LLC (0.44%). Insiders that own company stock include R Kent Mcgaughy Jr and Vivo Capital Ix, Llc.
View institutional ownership trends
.

How do I buy shares of Instil Bio?

Shares of TIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TIL) was last updated on 3/3/2024 by MarketBeat.com Staff